| First Author | Nishi K | Year | 2016 |
| Journal | Diabetes | Volume | 65 |
| Issue | 10 | Pages | 3015-27 |
| PubMed ID | 27385158 | Mgi Jnum | J:247243 |
| Mgi Id | MGI:5923080 | Doi | 10.2337/db16-0178 |
| Citation | Nishi K, et al. (2016) Nardilysin Is Required for Maintaining Pancreatic beta-Cell Function. Diabetes 65(10):3015-27 |
| abstractText | Type 2 diabetes (T2D) is associated with pancreatic beta-cell dysfunction, manifested by reduced glucose-stimulated insulin secretion (GSIS). Several transcription factors enriched in beta-cells, such as MafA, control beta-cell function by organizing genes involved in GSIS. Here we demonstrate that nardilysin (N-arginine dibasic convertase; Nrd1 and NRDc) critically regulates beta-cell function through MafA. Nrd1(-/-) mice showed glucose intolerance and severely decreased GSIS. Islets isolated from Nrd1(-/-) mice exhibited reduced insulin content and impaired GSIS in vitro. Moreover, beta-cell-specific NRDc-deficient (Nrd1(delbeta)) mice showed a diabetic phenotype with markedly reduced GSIS. MafA was specifically downregulated in islets from Nrd1(delbeta) mice, whereas overexpression of NRDc upregulated MafA and insulin expression in INS832/13 cells. Chromatin immunoprecipitation assay revealed that NRDc is associated with Islet-1 in the enhancer region of MafA, where NRDc controls the recruitment of Islet-1 and MafA transcription. Our findings demonstrate that NRDc controls beta-cell function via regulation of the Islet-1-MafA pathway. |
